Fox Jennifer A.
Insider CIK 1841557 · NUVB Chief Financial Officer · PROK Director · ZBIO See Remarks · APGE Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| APGE Apogee Therapeutics, Inc. | D To issuer deriv | 2026-09-03 | 2026-09-03 | 14,461 | — | $0 | 0 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | D To issuer deriv | 2026-09-03 | 2026-09-03 | 10,370 | — | $0 | 0 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | D To issuer deriv | 2026-09-03 | 2026-09-03 | 7,657 | — | $0 | 0 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | D To issuer | 2026-09-03 | 2026-09-03 | 34,824 | — | $0 | 0 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | D To issuer deriv | 2026-09-03 | 2026-09-03 | 7,657 | — | — | 0 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | D To issuer deriv | 2026-09-03 | 2026-09-03 | 14,461 | — | — | 0 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | D To issuer deriv | 2026-09-03 | 2026-09-03 | 10,370 | — | — | 0 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | D To issuer | 2026-09-03 | 2026-09-03 | 34,824 | — | — | 0 | SEC↗ |
| ZBIO Zenas BioPharma, Inc. | A Award deriv | 2026-06-15 | 2026-06-17 | 125,000 | — | $0 | 125,000 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | A Award deriv | 2026-06-09 | 2026-06-11 | 7,657 | — | $0 | 7,657 | SEC↗ |
| PROK PROKIDNEY CORP. | A Award deriv | 2026-05-28 | 2026-05-29 | 135,000 | — | $0 | 135,000 | SEC↗ |
| ZBIO Zenas BioPharma, Inc. | A Award | 2026-02-05 | 2026-06-17 | 1,592 | $13.35 | $21.3K | 1,592 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | A Award deriv | 2025-06-17 | 2025-06-20 | 14,461 | — | $0 | 14,461 | SEC↗ |
| ZBIO Zenas BioPharma, Inc. | A Award deriv | 2025-06-10 | 2025-06-12 | 150,000 | — | $0 | 150,000 | SEC↗ |
| PROK PROKIDNEY CORP. | A Award deriv | 2025-05-29 | 2025-06-02 | 125,862 | — | $0 | 125,862 | SEC↗ |
| ZBIO Zenas BioPharma, Inc. | A Award deriv | 2024-12-16 | 2024-12-18 | 8,125 | — | $0 | 8,125 | SEC↗ |
| ZBIO Zenas BioPharma, Inc. | A Award deriv | 2024-09-12 | 2024-09-16 | 155,000 | — | $0 | 155,000 | SEC↗ |
| PROK PROKIDNEY CORP. | A Award deriv | 2024-09-03 | 2024-09-04 | 9,535 | — | $0 | 9,535 | SEC↗ |
| APGE Apogee Therapeutics, Inc. | A Award deriv | 2024-06-05 | 2024-06-07 | 10,370 | — | $0 | 10,370 | SEC↗ |
| PROK PROKIDNEY CORP. | A Award deriv | 2024-05-30 | 2024-06-03 | 62,558 | — | $0 | 62,558 | SEC↗ |
| PROK PROKIDNEY CORP. | A Award deriv | 2023-07-12 | 2023-07-13 | 42,515 | — | $0 | 42,515 | SEC↗ |
| PROK PROKIDNEY CORP. | A Award deriv | 2023-07-12 | 2023-07-13 | 46,632 | — | $0 | 46,632 | SEC↗ |
| NUVB Nuvation Bio Inc. | A Award deriv | 2023-02-28 | 2023-03-02 | 600,000 | — | $0 | 600,000 | SEC↗ |
| PROK PROKIDNEY CORP. | A Award deriv | 2022-09-20 | 2022-09-22 | 129,370 | — | $0 | 129,370 | SEC↗ |
| NUVB Nuvation Bio Inc. | A Award deriv | 2022-08-29 | 2022-08-31 | 480,000 | — | $0 | 480,000 | SEC↗ |
| NUVB Nuvation Bio Inc. | A Award deriv | 2022-02-28 | 2022-03-02 | 600,000 | — | $0 | 600,000 | SEC↗ |
| NUVB Nuvation Bio Inc. | A Award deriv | 2021-02-10 | 2021-02-12 | 558,506 | — | $0 | 558,506 | SEC↗ |
| NUVB Nuvation Bio Inc. | A Award deriv | 2021-02-10 | 2021-02-12 | 398,935 | — | $0 | 398,935 | SEC↗ |